An Infectious cDNA Clone of SARS-CoV-2

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

A novel coronavirus from patients with pneumonia in China, 2019

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016

First case of 2019 novel coronavirus in the United States

Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030

SARS and MERS: recent insights into emerging coronaviruses

de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

Coutard, B., Valle, C., de Lamballerie, X. N., Canard, B., Seidah, N. G., & Decroly, É. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104742 · Cited by 1,706

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

Assiri, A., Al-Tawfiq, J. A., Al-Rabeeah, A. A., Al-Rabiah, F. A., Al-Hajjar, S., Al-Barrak, A., Flemban, H., Al-Nassir, W. N., Balkhy, H. H., Al-Hakeem, R. F., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70204-4 · Cited by 1,435

A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum

Shaner, N. C., Lambert, G. G., Chammas, A., Ni, Y., Cranfill, P. J. C., Baird, M. A., Sell, B., Allen, J. R., Day, R. N., Israelsson, M., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2413 · Cited by 1,260

A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence

Menachery, V. D., Yount, B. L., Debbink, K. M., Agnihothram, S., Gralinski, L. E., Plante, J. A., Graham, R. L., Scobey, T., Ge, X., Donaldson, E., et al. (2015) · Nature Medicine · doi:10.1038/nm.3985 · Cited by 901

Examination of SARS-CoV-2 serological test results from multiple commercial and laboratory platforms with an in-house serum panel

Lester, S. N., Stumpf, M. M., Freeman, B. D., Mills, L. A., Schiffer, J. M., Semenova, V. A., Jia, T., Desai, R., BROWNING, P. C., Alston, B., et al. (2024) · Access Microbiology · doi:10.1099/acmi.0.000463.v4 · Cited by 3

Development of a Cell Culture Model for Inducible SARS-CoV-2 Replication

Wang, X., Zhu, Y., Wu, Q., Jiang, N., Xie, Y., & Deng, Q. (2024) · Viruses · doi:10.3390/v16050708 · Cited by 3

Jamaican fruit bat (Artibeus jamaicensis) insusceptibility to mucosal inoculation with SARS-CoV-2 Delta variant is not caused by receptor compatibility

Port, J. R., Riopelle, J. C., van Tol, S., Wickenhagen, A., Bohrnsen, E., Sturdevant, D. E., Rosenke, R., Lovaglio, J., Lack, J., Anzick, S. L., et al. (2024) · npj Viruses · doi:10.1038/s44298-024-00037-1 · Cited by 3

Metabolic modeling elucidates phenformin and atpenin A5 as broad-spectrum antiviral drugs against RNA viruses

Renz, A., Hohner, M., Jami, R., Breitenbach, M., Josephs‐Spaulding, J., Dürrwald, J., Best, L., Dulière, V., Mialon, C., Bader, S. M., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08148-y · Cited by 4

Genetic Engineering Systems to Study Human Viral Pathogens from the Coronaviridae Family

Galkin, S., Anisenko, A. N., Shadrina, O., & Gottikh, M. (2022) · Molecular Biology · doi:10.1134/s0026893322010022 · Cited by 3

Reconstructed signaling and regulatory networks identify potential drugs for SARS-CoV-2 infectionPreprint

Ding, J., Lugo-Martinez, J., Yuan, Y., Huang, J., Hume, A. J., Suder, E. L., Mühlberger, E., Kotton, D. N., & Bar‐Joseph, Z. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.01.127589 · Cited by 3

Protein N -glycosylation is essential for SARS-CoV-2 infectionPreprint

Casas-Sánchez, A., Romero-Ramirez, A., Hargreaves, E., Ellis, C. C., Grajeda, B. I., Estevao, I. L., Patterson, E. I., Hughes, G. L., de Almeida, I. C., Zech, T., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.05.429940 · Cited by 3

Glucosidase inhibitors suppress SARS-CoV-2 in tissue culture and may potentiatePreprint

Reyes, H. M., Du, Y., Zhou, T., Xie, X., Shi, P., Weiss, S. R., & Block, T. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.14.444190 · Cited by 3

Pharmacological perturbation of intracellular dynamics as a SARS-CoV-2 antiviral strategyPreprint

Bakhache, W., Partiot, E., Lučanský, V., Bare, Y., Bonaventure, B., Goujon, C., Boriès, C., Deffieu, M. S., & Gaudin, R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.10.459410 · Cited by 3

Characterization of various remdesivir-resistant mutations of SARS-CoV-2 by mathematical modeling and molecular dynamics simulationPreprint

Torii, S., Kim, K. S., Koseki, J., Suzuki, R., Iwanami, S., Fujita, Y., Jeong, Y. D., Matsuura, Y., Shimamura, T., Iwami, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.22.481436 · Cited by 3

Chemokine Receptor Inhibitor vMIP-II Promoting Lymphocytes in COVID-19 Patients and Its Related Mechanism In VitroPreprint

Li, S., Wang, Y., Feng, L., Jiang, Z., Cong, F., Chen, Y., Dai, Z., Liu, S., Zhu, S., Fei, Z., et al. (2020) · doi:10.21203/rs.3.rs-33165/v1 · Cited by 3

New recommended policies for pathogen surveillance testing of researchers and improved stewardship of diagnostic DNAPreprint

Robinson‐McCarthy, L. R., Mijalis, A. J., Filsinger, G. T., de Puig, H., Donghia, N. M., Schaus, T. E., Rasmussen, R. A., Ferreira, R., Lunshof, J. E., Chao, G., et al. (2020) · doi:10.31219/osf.io/9svjq · Cited by 3

Trans-synaptic dwelling of SARS-CoV-2 particles perturbs neural synapse organization and functionPreprint

Partiot, E., Hirschler, A., Colomb, S., Lutz, W., Claeys, T., Delalande, F., Deffieu, M. S., Roels, J. R. E., Bons, J., Callon, D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.13.507484 · Cited by 3

Building Blocks of Understanding: Constructing a Reverse Genetics Platform for studying determinants of SARS-CoV-2 replicationPreprint

Olguin-Nava, M., Bohn, P. S., Hennig, T., Börtlein, C., Gribling-Burrer, A.-S., Schmidt, N., Caliskan, N., Dölken, L., Munschauer, M., & Smyth, R. P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.05.578560 · Cited by 3

Enhanced production of recombinant coxsackievirus A16 using a serum-free HEK293A suspension culture system for bivalent enterovirus vaccine development

Chen, Y., Shen, Y.-S., Fang, C., Chan, T.-T., Wu, S., Wang, J., Wu, S., & Liu, C. (2024) · Vaccine X · doi:10.1016/j.jvacx.2024.100559 · Cited by 2

Productive infection of the retinal pigment epithelium by SARS-CoV-2: Initial effects and consideration of long-term consequences

Hultgren, N. W., Petcherski, A., Torriano, S., Komirisetty, R., Sharma, M. B., Zhou, T., Burgess, B. L., Ngo, J., Osto, C. A., Shabane, B., et al. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae500 · Cited by 2

Infectivity and structure of SARS-CoV-2 after hydrogen peroxide treatment

Aliyari, S. R., Xie, G., Xia, X., Wang, L., Zhou, Z. H., & Cheng, G. (2025) · mBio · doi:10.1128/mbio.03994-24 · Cited by 2

SARS‐CoV‐2 Infection Reactivates HIV‐1 Replication From Latency in U1 Cells

Wang, X., Tang, W., Zhao, J., Ye, Z., Xie, H., & HEWLETT, I. K. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70049 · Cited by 2

Meeting report: 38th international conference on antiviral research in Las Vegas, United States of America, March 17–21, 2025

Jordan, R., Archin, N. M., Cagno, V., Feng, J. Y., Guo, H., Herrero, L. J., Janeba, Z., Meanwell, N. A., Moffat, J. F., Neyts, J. H., et al. (2025) · Antiviral Research · doi:10.1016/j.antiviral.2025.106222 · Cited by 2

Expression of spike and hemagglutinin-esterase proteins is necessary to recover infectious recombinant bovine coronavirus

Sugiura, Y., Takahashi, T., Ueno, S., Amarbayasgalan, S., Shimizu, K., Ujike, M., Suzuki, T., & Kamitani, W. (2025) · Journal of Virology · doi:10.1128/jvi.01027-25 · Cited by 2

A dual-reporter HCoV-OC43 for coronavirus biology and countermeasure development

Deng, X., Zou, J., Liang, Z., Ren, P., Shi, P., Menachery, V. D., & Xie, X. (2025) · Antiviral Research · doi:10.1016/j.antiviral.2025.106306 · Cited by 2

Discovery of Coronavirus Main Protease Inhibitors with Enhanced Brain Exposure and Potent Oral Efficacy in SARS-CoV-2 and MERS Infection Models

Lizzadro, L., Li, J., Taha, T. Y., Degotte, G., Detomasi, T. C., Belinchón, F. J. Z., Hantz, E. R., Huang, S., Matsui, Y., Henderson, W. R., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03015 · Cited by 2

Key residues in SARS-CoV-2 NSP3 hypervariable region are necessary to modulate early stress granule activity

Alvarado, R. E., Lokugamage, K. G., Garvanska, D. H., Estes, L. K., Ahearn, Y. P., McLeland, A. M., Moayyed, A., Chen, J. C., Mendez, B. L., Plante, J. A., et al. (2026) · Journal of Virology · doi:10.1128/jvi.02006-25 · Cited by 2

Research Progress of Coronavirus Reverse Genetics Technology

Han, Z., Han, J., Zhao, Y., Xu, C., Leng, X., Jia, B., Diao, N.-C., Liu, F., Cui, C., Liang, J., et al. (2026) · Journal of Medical Virology · doi:10.1002/jmv.70792 · Cited by 2

From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum

Khatua, K., Atla, S., Coleman, D. D., Blankenship, L. R., Alugubelli, Y. R., Vulupala, V. R., Guo, X. S., Xia, H., Kalveram, B., Walker, D. H., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69527-5 · Cited by 3

The safety, reactogenicity, and immunogenicity of the self-amplifying mRNA COVID-19 vaccine GRT-R910 as a booster in healthy adults

Whitaker, J. A., Rebolledo, P. A., Abate, G., Babu, T. M., Rouphael, N. G., Wald, A. P., Sahly, H. M. E., Jooss, K. U., Hart, M. G., Makowski, M., et al. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128358 · Cited by 2

Immunological imprinting shapes the cross-reactive antibody responses to the KP.2 and LP.8.1 vaccine doses

Kumar, S., Lai, L., Ellis, M., Patel, A. B., Joshi, D., Velden, J. W. V., Faraj, J. A., Wimalasena, S., Pallavi, R. R., Iriss, J., et al. (2026) · Journal of Virology · doi:10.1128/jvi.00749-26 · Cited by 2

Mitochondrial OXPHOS restricts SARS-CoV-2 replication

Albrecht, Y. E. S., Morrow, R. M., Kenney, D., Olali, A. Z., Wacquiez, A., Chehadeh, N., Cen, Z., Haltom, J., Chen, I. G., Ranshing, S., et al. (2026) · Science Advances · doi:10.1126/sciadv.adz3081 · Cited by 2

Tracking Plasmacytoid Dendritic Cell Response to Physical Contact with Infected Cells

Ribeiro, M. S., Joshi, G., Décembre, É., Nuovo, C., Bosseboeuf, A., Bellomo, A., Venet, M., Assil, S., & Dreux, M. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2938-3_21 · Cited by 2

Distinct in vitro and in vivo neutralization profiles of monoclonal antibodies elicited by the receptor binding domain of the ancestral SARS‐CoV‐2

Kwon, H. J., Zhang, J., Kosikova, M., Tang, W., Ortega‐Rodriguez, U., Peng, H., Meseda, C. A., Pedro, C. L., Schmeisser, F., Lu, J., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28673 · Cited by 2

Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways

Gagné, M., Flynn, B. J., Honeycutt, C. C., Flebbe, D. R., Andrew, S. F., Provost, S. J., McCormick, L., Ry, A. V., McCarthy, E. E., Todd, J.-P. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51046-w · Cited by 3

Development and characterization of reverse genetics systems of feline infectious peritonitis virus for antiviral research

Gu, G., Fung, T. S., Hung, W. T., Osterrieder, N., & Go, Y. Y. (2024) · Veterinary Research · doi:10.1186/s13567-024-01373-z · Cited by 2

Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity

Moreno, A., Manning, K. E., Azeem, M. I., Nooka, A. K., Ellis, M. L., Manalo, R. J., Switchenko, J. M., Wali, B., Kaufman, J. L., Hofmeister, C. C., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00999-6 · Cited by 2

Facilitating and restraining virus infection using cell-attachable soluble viral receptors

Zhang, H., Wang, Z., Nguyen, H. T. T., Pontelli, M. C., Qi, W., Rao, L., Liu, Z., Whelan, S. P. J., & Zhu, J. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2414583121 · Cited by 3

Meeting report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20–24, 2024, organized by the International Society for Antiviral Research

Welch, S. R., Bilello, J. P., Carter, K. L., Delang, L., Dirr, L., Durantel, D., Feng, J. Y., Gowen, B. B., Herrero, L. J., Janeba, Z., et al. (2024) · Antiviral Research · doi:10.1016/j.antiviral.2024.106037 · Cited by 2

A yeast-assembled, plasmid-launched reverse genetics system for the murine coronavirus MHV-A59

Sterling, C. E., Wilson, N. R., Harris, D. Y., & Smith, E. C. (2025) · Journal of General Virology · doi:10.1099/jgv.0.002065 · Cited by 2

Advances in the development of infectious clones of human coronaviruses and related applications

Liu, G., Tan, R., Wu, Y., Wang, M., Huang, B., & Tan, W. (2025) · Biosafety and Health · doi:10.1016/j.bsheal.2025.01.003 · Cited by 2

Cells that survive acute SARS-CoV-2 infection contribute to inflammation and lung regeneration in mice

Pan, R., Meyerholz, D. K., & Perlman, S. M. (2025) · mBio · doi:10.1128/mbio.03693-24 · Cited by 2

Comparison of viral propagation and drug response among SARS-CoV-2 VOCs using replicons capable of recapitulating virion assembly and release

Tian, L., Liu, Q., Pei, R., Chen, Y., Xu, C., Tang, J., Sun, H. X., Liu, K., Yang, Q., Yang, L., et al. (2022) · Virologica Sinica · doi:10.1016/j.virs.2022.06.008 · Cited by 2

Current Challenges for the Effective Management of the COVID-19 Pandemic

Sinha, V., Saxena, S., Pandey, S., Dwivedi, S., Thakur, S., Asea, A. A. A., Dixit, A. K., Dixit, V., Vishvakarma, N. K., & Shukla, D. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-85113-2_8 · Cited by 2

Procedures and potential pitfalls for constructing a bee-infecting RNA virus clone

Huang, W., Li, R., Jin, L., & Huang, S. (2022) · Frontiers in Insect Science · doi:10.3389/finsc.2022.908702 · Cited by 2

Research Methodology to Define the Introduction of the SARS-CoV-2 B.1.429 Variant in HawaiiPreprint

Maison, D. P., & Nerurkar, V. R. (2021) · Research Square · doi:10.21203/rs.3.rs-378702/v1 · Cited by 2

Inhibition of SARS-CoV-2 spike protein palmitoylation reduces virus infectivityPreprint

Ramadan, A., Mayilsamy, K., McGill, A. R., Ghosh, A., Giulianotti, M. A., Donow, H. M., Mohapatra, S. S., Mohapatra, S., Chandran, B., Deschenes, R. J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.07.463402 · Cited by 2

Genomic Analysis of SARS-CoV-2 Variants of Concern Circulating in Hawai’i to Facilitate Public-Health PoliciesPreprint

Maison, D. P., Cleveland, S. B., & Nerurkar, V. R. (2021) · Research Square · doi:10.21203/rs.3.rs-378702/v3 · Cited by 2

An in vitro workflow to create and modify novel infectious clones using replication cycle reactionPreprint

Marano, J. M., Cereghino, C., Finkielstein, C. V., & Weger‐Lucarelli, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1894417/v1 · Cited by 2

Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platformPreprint

Kipfer, E. T., Hauser, D., Lett, M. J., Otte, F., Urda, L., Zhang, Y., Lang, C. M. R., Chami, M., Mittelholzer, C., & Klimkait, T. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.11.540343 · Cited by 2

SARS-CoV-2 hijacks fragile X mental retardation proteins for efficient infectionPreprint

Garvanska, D. H., Alvarado, R. E., Mundt, F. O., Nilsson, E., Duel, J. K., Coscia, F., Lindqvist, R., Lokugamage, K. G., Johnson, B. A., Plante, J. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.01.555899 · Cited by 2

Metabolic Modeling Elucidates Phenformin and Atpenin A5 as Broad-Spectrum Antiviral DrugsPreprint

Renz, A., Hohner, M., Breitenbach, M., Josephs‐Spaulding, J., Dürrwald, J., Best, L., Jami, R., Μαρίνος, Γ., Cabreiro, F., Dräger, A., et al. (2023) · Preprints.org · doi:10.20944/preprints202210.0223.v2 · Cited by 1

Persistence of an Infectious Form of SARS-CoV-2 Post Protease Inhibitor Treatment of Permissive Cells in vitroPreprint

Nair, M. S., Luck, M. I., Huang, Y., Sabo, Y., & Ho, D. D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.20.572655 · Cited by 2

SARS-CoV-2 predation of Golgi-bound PI4P primes the massive activation of the DNA Damage Response kinase ATM in the cytoplasmPreprint

Rebendenne, A., Soulet, C., Valadão, A. L. C., Bonaventure, B., McKellar, J., Moncorgé, O., Goujon, C., & Moriel‐Carretero, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.05.626967 · Cited by 2

The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2Preprint

Suryawanshi, R. K., Jaishankar, P., Correy, G. J., Rachman, M. M., O’Leary, P. C., Taha, T. Y., Belinchón, F. J. Z., McCavitt-Malvido, M., Doruk, Y. U., Stevens, M. G., et al. (2025) · eLife · doi:10.7554/elife.103484.1 · Cited by 2

The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2Preprint

Suryawanshi, R. K., Jaishankar, P., Correy, G. J., Rachman, M. M., O’Leary, P. C., Taha, T. Y., Matsui, Y., Belinchón, F. J. Z., McCavitt-Malvido, M., Doruk, Y. U., et al. (2025) · eLife · doi:10.7554/elife.103484.2 · Cited by 2

Positive‐strand RNA viruses—a Keystone Symposia report

Cable, J., Denison, M. R., Kielian, M. C., Jackson, W. T., Bartenschlager, R. F. W., Ahola, T., Mukhopadhyay, S., Fremont, D. H., Kuhn, R. J., Shannon, A., et al. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14957 · Cited by 1

Pseudotyped Viruses for Coronaviruses

Wang, M., Nie, J., & Wang, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-0113-5_7 · Cited by 1

The Efficiency of Various DNA Polymerases for Amplification of Long Sequences from Genomic DNA and cDNA of Cultivated Potatoes

Antipov, A. D., & Zlobin, N. (2023) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683823040026 · Cited by 1

Calreticulin Regulates SARS-CoV-2 Spike Protein Turnover and Modulates SARS-CoV-2 Infectivity

Rahimi, N., White, M. R., Amraei, R., Lotfollahzadeh, S., Xia, C., Michalak, M., Costello, C. E., & Mühlberger, E. (2023) · Cells · doi:10.3390/cells12232694 · Cited by 2

Construction and characterization of an infectious cDNA clone of turtle grass virus X from a naturally infected Thalassia testudinum plant

Alvarado‐Marchena, L., Furman, B. T., & Breitbart, M. (2024) · mBio · doi:10.1128/mbio.02828-24 · Cited by 1

Harnessing 2D and 3D human endometrial cell culture models to investigate SARS-CoV-2 infection in early pregnancy

Liu, A., Ruétalo, N., Xavier, J. P. R., Lankapalli, A. K., Admard, J., Camarena-Sainz, M., Brucker, S. Y., Singh, Y., Schindler, M., & Salker, M. S. (2024) · Clinical Science · doi:10.1042/cs20241215 · Cited by 1

Reverse Genetics-Based Methodology for Molecular Virology Study

Zhang, Y., Zhang, T., Xiong, Y., Zheng, C., & Li, L. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4615-1_26 · Cited by 1

Developing Synthetic Full-Length SARS-CoV-2 cDNAs and Reporter Viruses for High-Throughput Antiviral Drug Screening

Rohamare, M., Kaushik, N., Khan, J. Q., Balouchi, M., López-Orozco, J., Kozak, R. A., Hobman, T. C., Falzarano, D., Kumar, A., & Wilson, J. A. (2025) · Viruses · doi:10.3390/v18010044 · Cited by 1

Stalling the Enemy: Targeting Nsp13 for Next-Generation SARS-CoV-2 Antivirals

Castro, J. M., Slack, R. L., Ong, Y. T., Zhang, H., Gifford, L. B., Courouble, V. V., Aiken, R. M., Shankar, V., O’Leary, T. R., Griffin, P. R., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062587 · Cited by 1

Hypoxia-inducible Factor 1α–dependent Induction of Alveolar miR-147b and Direct Targeting of Viral RNA in SARS-CoV-2–associated Acute Respiratory Distress Syndrome

Yuan, X., Kim, J., Figarella, K., Wang, Y., Makarevich, O. D., Ruan, W., Hu, Y., Xie, X., Mills, T. W., Karmouty‐Quintana, H., et al. (2026) · Anesthesiology · doi:10.1097/aln.0000000000006306 · Cited by 1

Advances in the reverse genetics system for RNA viruses

Suzuki, T., & Saito, A. (2022) · Folia Pharmacologica Japonica · doi:10.1254/fpj.21072 · Cited by 1

Modern Approaches to Molecular Genetics of Viruses in the Study of the Members of the Family Coronaviridae

Supotnitskiy, M. V. (2021) · Journal of NBC Protection Corps · doi:10.35825/2587-5728-2021-1-3-217-235 · Cited by 1

High-Content Imaging-Based Assay for SARS-CoV-2-Neutralizing Antibodies

Rocha, V. P. C., Machado, B. A. S., Quadros, H. C., Fernandes, A. M. S., Fiuza, B. S. D., Meira, C. S., da Silva, V. T. B., Evangelista, A. F., Fonseca, L. M. D. S., Badaró, R. J. D. S., et al. (2024) · Vaccines · doi:10.3390/vaccines12030236 · Cited by 1

Pharmacological approaches to the treatment of COVID-19 patients

Sowers, L. C., Blanton, L. S., Weaver, S. C., Urban, R. J., & Mouton, C. P. (2020) · Journal of Translational Science · doi:10.15761/jts.1000394 · Cited by 1

Deep Learning Technology for Tackling COVID-19 Pandemic

Soliman, M., Darwish, A., & Hassanien, A. E. (2021) · Studies in systems, decision and control · doi:10.1007/978-3-030-63307-3_9 · Cited by 1

Prediksi Gejala Autism Spectrum Disorders pada Remaja Menggunakan Optimasi Particle Swarm Optimization dan Algoritma Support Vector Machine

Kurniawan, I. B. (2020) · INFORMATICS FOR EDUCATORS AND PROFESSIONAL Journal of Informatics · doi:10.51211/itbi.v4i2.1306 · Cited by 1

Absence of detectable SARS-CoV-2 replication in ex vivo cultured cornea and cornea-derived epithelial cells

Bayyoud, T., Syrigos, G. V., Ruétalo, N., Wude, J., Businger, R., Hu, D., Iftner, A., Thaler, S., & Schindler, M. (2022) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-022-05776-6 · Cited by 1

Trends on Human Norovirus Virus-like Particles (HuNoV-VLPs) and Strategies for the Construction of Infectious Viral Clones toward In Vitro Replication

Sion, E., Rahim, S. A., & Muhamad, M. (2023) · Life · doi:10.3390/life13071447 · Cited by 1

Discovery of a Novel Merbecovirus DNA Clone Contaminating Agricultural Rice Sequencing Datasets from Wuhan, China

Jones, A., Zhang, D., Massey, S. E., Deigin, Y., Nemzer, L. R., & Quay, S. C. (2024) · Journal of Bioinformatics and Systems Biology · doi:10.26502/jbsb.5107086 · Cited by 1

Generation of a SARS-CoV-2 Replicon as a Model System to Dissect Virus Replication and Antiviral InhibitionPreprint

He, X. C., Quan, S., Xu, M., Rodriguez, S., Goh, S. L., Wei, J., Fridman, A., Koeplinger, K. A., Carroll, S. S., Grobler, J. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.12.422532 · Cited by 1

A Trans-Complementation System for SARS-CoV-2Preprint

Zhang, X., Liu, Y., Liu, J., Bailey, A. L., Plante, K. S., Plante, J. A., Zou, J., Xia, H., Bopp, N., Aguilar, P., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3770930 · Cited by 1

Genomic Analysis of SARS-CoV-2 Variants of Concern Circulating in Hawai’i to Facilitate Public-Health PoliciesPreprint

Maison, D. P., Cleveland, S. B., & Nerurkar, V. R. (2021) · Research Square · doi:10.21203/rs.3.rs-378702/v2 · Cited by 1

A method for the generation of pseudotyped virus particles bearing SARS coronavirus spike protein in high yieldsPreprint

Fujioka, Y., Kashiwagi, S., Yoshida, A., Satoh, A. O., Fujioka, Y., Amano, M., Yamauchi, Y., & Ohba, Y. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.30.454063 · Cited by 1

A broadly neutralizing biparatopic Nanobody protects mice from lethal challenge with SARS-CoV-2 variants of concernPreprint

Wagner, T. R., Schnepf, D., Beer, J., Klingel, K., Ruétalo, N., Kaiser, P. D., Junker, D., Sauter, M., Traenkle, B., Frecot, D. I., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.08.455562 · Cited by 1

Algorithm for the Quantitation of Variants of Concern for Rationally Designed Vaccines Based on the Isolation of SARS-CoV-2 Hawaiʻi Lineage B.1.243Preprint

Maison, D. P., Ching, L. L., Cleveland, S. B., Tseng, A. C., Nakano, E. T., Shikuma, C. M., & Nerurkar, V. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.18.455536 · Cited by 1

BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other VariantsPreprint

Liu, J., Liu, Y., Xia, H., Zou, J., Weaver, S. C., Swanson, K. A., Cai, H., Cutler, M. W., Cooper, D., Muik, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.13.460163 · Cited by 1

Human NLRP1 Is a Sensor of 3CL Proteases from Pathogenic Coronaviruses in Lung Epithelial CellsPreprint

Planès, R., Pinilla, M., Santoni, K., Hessel, A., Lay, K., Paillette, P., Valadão, A. L. C., Robinson, K. S., Bastard, P., Rossi, I., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3948202 · Cited by 1

Using a reverse genetics system to generate recombinant SARS-CoV-2 expressing robust levels of reporter genesPreprint

Ye, C., & Martínez‐Sobrido, L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.21.492922 · Cited by 1

Calpain-2 mediates SARS-CoV-2 entry and represents a therapeutic targetPreprint

Zeng, Q., Antia, A., Puray‐Chavez, M., Kutluay, S. B., & Ding, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.29.518418 · Cited by 1

T492I mutation alters SARS-CoV-2 properties via modulating viral non-structural proteinsPreprint

Lin, X., Sha, Z., Trimpert, J., Kunec, D., Jiang, C., Xiong, Y., Xu, B., Zhu, Z., Xue, W., & Wu, H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.15.524090 · Cited by 1

The potentials of Pasteurella multocida OmpA protein as the candidate for sub-unit vaccine and for the development of an ELISA kit to evaluate the vaccine response in the animalsPreprint

Shoaib, R., Nawaz, M. A., Absar, M. M., Ali, Z., Sharif, M. N., Rabaan, A. A., Mashraqi, M. M., Aljeldah, M. M., Alwashmi, A. S. S., Aldali, J. A., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2553403/v1 · Cited by 1

Tetherin restricts SARS-CoV-2 replication despite antagonistic effects of Spike and ORF7aPreprint

Hagelauer, E., Lotke, R., Kmieć, D., Hu, D., Hohner, M., Stopper, S., Layer, M., Nchioua, R., Kirchhoff, F., Sauter, D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.28.550997 · Cited by 1

Nanobodies against SARS-CoV-2 non-structural protein Nsp9 inhibit viral replication by targeting innate immunityPreprint

Venit, T., Blavier, J., Maseko, S. B., Shu, S., Espada, L., Breunig, C., Holthoff, H., Desbordes, S. C., Lohse, M. J., Esposito, G., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.12.561992 · Cited by 1

Noncoding RNA Regions: Unveiling Novel Insights into AIDS PathogenesisPreprint

Odah, M. (2024) · Preprints.org · doi:10.20944/preprints202403.0392.v1 · Cited by 1

Metabolic Modeling Elucidates Phenformin and Atpenin A5 as Broad-Spectrum Antiviral DrugsPreprint

Renz, A., Hohner, M., Breitenbach, M., Josephs‐Spaulding, J., Dürrwald, J., Best, L., Dulière, V., Mialon, C., Bader, S. M., Jami, R., et al. (2024) · Preprints.org · doi:10.20944/preprints202210.0223.v3 · Cited by 1

SARS-CoV2 infection triggers reactive astrocyte states and inflammatory conditions in long-term Human Cortical OrganoidsPreprint

Colinet, M., Chiver, I., Bonafina, A., Masset, G., Almansa, D., Valentin, E. D., Twizere, J., Nguyen, L., & Espuny-Camacho, I. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.16.589036 · Cited by 1

Deletion of the Envelope gene attenuates SARS-CoV-2 infection by altered spike localization and increased cell-to-cell transmission

Fischer, H. L., Shanmugapriya, S., Kline, C., Duprex, W. P., McCarthy, K. R., Watkins, S. C., Conway, J. F., & Ambrose, Z. (2026) · mBio · doi:10.1101/2025.05.20.655126 · Cited by 1

Programmable translational inhibition by a molecular glue-oligonucleotide conjugatePreprint

Wang, S., Kovalski, J. R., Belinchón, F. J. Z., Bennett, M., Kuzuoğlu‐Öztürk, D., Li, Q., Stevenson, E. J., Liu, J., Krogan, N. J., Ott, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.15.664547 · Cited by 1

Coronavirus membrane protein with a fluorescent protein tag enables tracking of virus particles in live cellsPreprint

Stefanos, B., Green, N. R. B., Nadig, I., Lapierre, L. A., Goldenring, J. R., Hogue, I. B., Glenn, H. L., & Hogue, B. G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.29.696688 · Cited by 1

Antagonism of stress granules key for SARS-CoV-2 infection and pathogenesisPreprint

Alvarado, R. E., Chen, J., Lokugamage, K. G., Zhou, Y., Estes, L. K., Morgan, A. L., Ahearn, Y. P., Deng, X., Lai, L., Moayyed, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.16.732644 · Cited by 1

SARS ve MERS aşılarının gizemi, Coronavirus aşısına yeni yaklaşımlar

Şimşek, A., & Avcı, O. (2020) · Eurasian journal of veterinary sciences · doi:10.15312/eurasianjvetsci.2020.295

COVID-19 hastalığının immünopatolojisi ve immünolojisindeki güncel veriler

Azkur, D., & Azkur, A. K. (2020) · Eurasian journal of veterinary sciences · doi:10.15312/eurasianjvetsci.2020.290

Advances in treatment of COVID-19

Wu, Q., Xu, Y., Peng, W., Feng, F., Wang, Z., Han, D., Gu, C., & Zhou, X. (2020) · Integrative Respiratory Medicine · doi:10.1051/irm/2020001

Design and evaluation of small interfering RNAs for the treatment of Severe Acute Respiratory Syndrome-Coronavirus-2

Zhang, W., Daher, A., Gatignol, A., & Scarborough, R. J. (2021) · McGill Science Undergraduate Research Journal · doi:10.26443/msurj.v16i1.62

Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacityPreprint

Koide, A., Panchenko, T., Wang, C., Thannickal, S. A., Romero, L. A., Teng, K. W., Li, F.-Z., Akkapeddi, P., Corrado, A. D., Caro, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.03.454782

Engineering RNA viruses with unnatural amino acid to evoke adjustable immune response in micePreprint

Zheng, Z., Wang, Y., Wu, X., Zhang, H., Chen, H., Lin, H., Shen, Y., & Xia, Q. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.04.471206

A highly attenuated SARS-CoV-2 related pangolin coronavirus variant has a 104nt deletion at the 3′-terminus untranslated regionPreprint

Lu, S., Luo, S., Liu, C., Li, M., An, X., Li, M., Hou, J. W., Fan, H., Mao, P., Tong, Y., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.07.479352

A rebuttal to “The proximal origin of SARS-CoV-2”: Covid-19 is plausibly from a manmade virus. Emergency regulatory reform for stopping epidemicsPreprint

Stout, T. R. (2020) · doi:10.31219/osf.io/usx58

Engineering SARS-CoV-2 using a reverse genetic system

Xie, X., Lokugamage, K. G., Zhang, X., Vu, M. N., Muruato, A. E., Menachery, V. D., & Shi, P. (2021) · Nature Protocols · doi:10.1038/s41596-021-00491-8 · Cited by 171

Efficient and modular reverse genetics system for rapid generation of recombinant severe acute respiratory syndrome coronavirus 2

Bae, S., & Myoung, J. (2025) · The Journal of Microbiology · doi:10.71150/jm.2504015 · Cited by 3

Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reactionPreprint

Torii, S., Ono, C., Suzuki, R., Morioka, Y., Anzai, I., Fauzyah, Y., Maeda, Y., Kamitani, W., Fukuhara, T., & Matsuura, Y. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.23.309849 · Cited by 16

A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses

Amarilla, A. A., Sng, J. D. J., Parry, R. H., Deerain, J. M., Potter, J. R., Setoh, Y. X., Rawle, D. J., Le, T. T., Modhiran, N., Wang, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23779-5 · Cited by 159

Bacterial Artificial Chromosome Reverse Genetics Approaches for SARS-CoV-2

Chiem, K., Nogales, A., Almazán, F., Ye, C., & Martínez‐Sobrido, L. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3533-9_9 · Cited by 1